2012
DOI: 10.3109/02713683.2011.635404
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of Postoperative Scarring with Tacrolimus and Octreotide in Experimental Glaucoma Filtration Surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(10 citation statements)
references
References 32 publications
(30 reference statements)
0
9
0
1
Order By: Relevance
“…A variety of alternative antiscarring strategies (Table 1), such as photodynamic therapy,101–104 saratin (Merck KGaA),105,106 sonepcizumab (Lpath, Inc., San Diego, CA, USA),107 doxycycline (Pfizer Inc.),108 pirfenidone (InterMune, Brisbane, CA, USA),109,110 tacrolimus (Astellas Pharma Inc., Tokyo, Japan),111 and octreotide (Novartis),111 have also shown promising results by improving the outcome of surgery in a standard rabbit model. Although many agents have been evaluated in preclinical models for glaucoma filtration surgery, few have been found to be beneficial in large prospective comparative clinical trials and none have replaced mitomycin C or 5-fluorouracil in clinical practice so far.…”
Section: Future Perspectivesmentioning
confidence: 99%
“…A variety of alternative antiscarring strategies (Table 1), such as photodynamic therapy,101–104 saratin (Merck KGaA),105,106 sonepcizumab (Lpath, Inc., San Diego, CA, USA),107 doxycycline (Pfizer Inc.),108 pirfenidone (InterMune, Brisbane, CA, USA),109,110 tacrolimus (Astellas Pharma Inc., Tokyo, Japan),111 and octreotide (Novartis),111 have also shown promising results by improving the outcome of surgery in a standard rabbit model. Although many agents have been evaluated in preclinical models for glaucoma filtration surgery, few have been found to be beneficial in large prospective comparative clinical trials and none have replaced mitomycin C or 5-fluorouracil in clinical practice so far.…”
Section: Future Perspectivesmentioning
confidence: 99%
“…25 Arslan et al found that topically administration of Tacrolimus and Octreotide effectively reduced the subconjuntival scarring response 2 weeks after experimental glaucoma filtration surgery. 26 In a comparative study with Interceed and Surgicel, Akyol and Akpolat 27 observed that both these agents seem to suppress vascularization but they have no significant effect on fibroblast proliferation. In our study, we studied the effect of oral steroid, nonsteroid antiinflamatuar drug (NSAID) and Colchicine on bleb vascularization.…”
Section: Discussionmentioning
confidence: 99%
“…[25][26][27] The next intervention is a minimally invasive reparative surgery of the filtering bleb by transconjunctival needle revision in case of ineffectivity. 23,24,26 Finally, if filtration is still inadequate, an invasive reparative surgery of the filtering bleb or another filtering procedure at a new location may be required.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Diante dessas dificuldades e da necessidade de novas opções de drogas moduladoras da cicatrização, a quantidade de estudos visando a descoberta de novos fármacos para o tratamento adjuvante em cirurgias filtrantes do glaucoma vem crescendo nos últimos anos, abrindo perspectiva para a pesquisa de novos agentes moduladores (ARSLAN et al, 2012;LÜKE et al, 2010;LUKOWSKI et al, 2013;MIN et al, 2012b;RIBEIRO, 2011;TURGUT et al, 2014TURGUT et al, , 2015ZHONG et al, 2011).…”
Section: α-Alfaunclassified